Zobrazeno 1 - 10
of 17
pro vyhledávání: '"P C, Enzinger"'
Autor:
Anupama Singh, MD, Miles McAllister, BA, Ashley L. Deeb, MD, Sue X. Wang, MD, Kristen Rizza, BS, MPH, Vincent T. Ho, MD, Harvey Mamon, MD, PhD, Peter C. Enzinger, MD, Michael T. Jaklitsch, MD, Jon O. Wee, MD
Publikováno v:
Annals of Thoracic Surgery Short Reports, Vol 2, Iss 3, Pp 535-539 (2024)
Background: Development of secondary esophageal cancer after hematopoietic stem cell transplantation has been described; however, there is little consensus on treatment and surveillance for these patients. The objective of this study was to describe
Externí odkaz:
https://doaj.org/article/8e8b394806ba4f25b3e6963d88f5e096
Autor:
Harshabad Singh, Kristen E. Lowder, Kevin Kapner, Ronan J. Kelly, Hui Zheng, Nadine Jackson McCleary, Thomas A. Abrams, Jennifer A. Chan, Eileen M. Regan, Samuel J. Klempner, Alison M. Hannigan, Joshua Remland, Lauren K. Brais, Elizabeth Andrews, Matthew Yurgelun, James M. Cleary, Douglas A. Rubinson, Lauren L. Ritterhouse, Garrett Maron, Andrew J. Aguirre, Jeffrey A. Meyerhardt, Emma Gardecki, Jochen K. Lennerz, Brian M. Wolpin, Peter C. Enzinger
Publikováno v:
Nature Communications, Vol 15, Iss 1, Pp 1-15 (2024)
Abstract Preclinical studies suggest that simultaneous HER2/VEGF blockade may have cooperative effects in gastroesophageal adenocarcinomas. In a single-arm investigator initiated clinical trial for patients with untreated advanced HER2+ gastroesophag
Externí odkaz:
https://doaj.org/article/df43da4c105c4a28ae7e276e1e916753
Autor:
Michael Dougan, James M Cleary, Benjamin Schlechter, Sarah Slater, Kimmie Ng, Brian M Wolpin, Stephanie K Dougan, Anuj K Patel, Nadine J McCleary, Douglas A Rubinson, Lauren K Brais, Peter C Enzinger, Thomas A Abrams, Matthew B Yurgelun, Victoire Cardot-Ruffino, Naima Bollenrucher, Luisa Delius, S Jennifer Wang, Joshua Remland, C Elizabeth Keheler, Keri M Sullivan, Leah H Biller, Kimberly Perez, Harshabad Singh
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 11, Iss 6 (2023)
Background Recombinant granulocyte colony-stimulating factor (G-CSF) is routinely administered for prophylaxis or treatment of chemotherapy-induced neutropenia. Chronic myelopoiesis and granulopoiesis in patients with cancer has been shown to induce
Externí odkaz:
https://doaj.org/article/ffb2b2c1043940efb1756d04927a4861
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Jeffrey A Meyerhardt, James M Cleary, Kimmie Ng, Brian M Wolpin, Nancy Campbell, Elizabeth Brighton, Nadine J McCleary, Peter C Enzinger, Justin C Brown, Thomas A Abrams, Douglas Rubinson, Matthew B Yurgelun
Publikováno v:
BMJ Open Sport & Exercise Medicine, Vol 8, Iss 2 (2022)
Externí odkaz:
https://doaj.org/article/e42ac267f84f498980d2b004ac6cd849
Autor:
Hui Zheng, Eirini Pectasides, Mohamed Uduman, Charles S Fuchs, James M Cleary, Adam J Bass, Jérémy Augustin, Leonie K de Klerk, Anuj K Patel, Sarah Derks, Nihal Raman, Fahire G Akarca, Nadine J McCleary, Douglas A Rubinson, Jeffrey W Clark, Bridget Fitzpatrick, Lauren K Brais, Megan E Cavanaugh, Amanda J Rode, Melissa G Jean, Patrick H Lizotte, Matthew J Nazzaro, Peter C Enzinger
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss 9 (2021)
Externí odkaz:
https://doaj.org/article/88b5dffda1124385a9d172a7073bce20
Autor:
Kumar K. Shashi, Rachna Madan, Mark M. Hammer, Steven van Hedent, Suzanne C. Byrne, Eric J. Schmidlin, Harvey Mamon, Hiroto Hatabu, Peter C. Enzinger, Victor H. Gerbaudo
Publikováno v:
European Journal of Radiology Open, Vol 7, Iss , Pp 100291- (2020)
Background: A multidisciplinary team approach to the management of esophageal cancer patients leads to better clinical decisions. Purpose: The contribution of CT, endoscopic and laparoscopic ultrasound to clinical staging and treatment selection by m
Externí odkaz:
https://doaj.org/article/45c1ac5fa8cd434fbc89c95624e9d757
Autor:
Jeffrey A Meyerhardt, Marek Ancukiewicz, Thomas A Abrams, Deborah Schrag, Peter C Enzinger, Jennifer A Chan, Matthew H Kulke, Brian M Wolpin, Michael Goldstein, Lawrence Blaszkowsky, Andrew X Zhu, Meaghan Elliott, Eileen Regan, Rakesh K Jain, Dan G Duda
Publikováno v:
PLoS ONE, Vol 7, Iss 6, p e38231 (2012)
To determine the maximum tolerated dose (MTD) and safety, and explore efficacy and biomarkers of vandetanib with cetuximab and irinotecan in second-line metastatic colorectal cancer.Vandetanib (an orally bioavailable VEGFR-2 and EGFR tyrosine kinases
Externí odkaz:
https://doaj.org/article/be6eb12b430845b7bbb31be9b632a516
Autor:
P C, Enzinger, D H, Ilson
Publikováno v:
Oncology (Williston Park, N.Y.). 14(12 Suppl 14)
Irinotecan (Camptosar) has shown activity in several solid tumor malignancies, including gastric and pancreatic cancer. In vitro studies suggest antitumor activity in esophageal cancer cell lines. Sequence-dependent synergy has been demonstrated in v
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::3c9c73d9016f33bd56e73187befbb64c
https://pubmed.ncbi.nlm.nih.gov/11200145
https://pubmed.ncbi.nlm.nih.gov/11200145
Publikováno v:
Seminars in oncology. 26(5 Suppl 15)
The incidence of esophageal cancer continues to increase due to a rapid increase in adenocarcinoma of the distal esophagus and gastroesophageal junction. At least 50% of patients present with metastatic cancer and most patients with localized disease
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::db981d99fc3b54b9448f23e06f67feef
https://pubmed.ncbi.nlm.nih.gov/10566606
https://pubmed.ncbi.nlm.nih.gov/10566606